Loading...
The Pharmacological Burden of Comorbidities in Acromegaly
Background: Acromegaly is characterized by excess GH and elevated IGF-I often treated by surgery, pharmacotherapy (somatostatin analogs, GH receptor antagonists, dopamine agonists) and/or radiotherapy.(1) Common associated comorbidities include cardiovascular disorders and hypopituitarism, often req...
Na minha lista:
| Udgivet i: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090600/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1324 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|